Evidence map›Paper›PMID 40044747›Full record

ArticleScientific reports2025

Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations.

Lucy Petagine, Mohammed G Zariwala, Satyanarayana Somavarapu, Stefanie Ho Yi Chan, Evrim A Kaya, Vinood B Patel

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucy PetagineCentre for Nutraceuticals, School of Life Sciences, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK.
Mohammed G ZariwalaCentre for Nutraceuticals, School of Life Sciences, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK.
Satyanarayana SomavarapuDepartment of Pharmaceutics, UCL School of Pharmacy, London, UK.
Stefanie Ho Yi ChanCentre for Nutraceuticals, School of Life Sciences, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK.
Evrim A KayaCentre for Nutraceuticals, School of Life Sciences, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK.
Vinood B PatelCentre for Nutraceuticals, School of Life Sciences, University of Westminster, 115 New Cavendish Street, London, W1W 6UW, UK. v.b.patel@westminster.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol-related liver disease (ARLD) is a global health issue causing significant morbidity and mortality, due to lack of suitable therapeutic options. ARLD induces a spectrum of biochemical and cellular alterations, including chronic oxidative stress, mitochondrial dysfunction, and cell death, resulting in hepatic injury. Natural antioxidant compounds such as curcumin have generated interest in ARLD due to their ability to scavenge reactive oxygen species (ROS), however, therapy using these compounds is limited due to poor bioavailability and stability. Therefore, the aim of this study was to assess the antioxidant potential of free antioxidants and curcumin entrapped formulations against oxidative damage in an ARLD cell model. HepG2 (VL-17A) cells were treated with varying concentrations of alcohol (from 200 to 350 mM) and parameters of oxidative stress and mitochondrial function were assessed over 72 h. Data indicated 350 mM of ethanol led to a significant decrease in cell viability at 72 h, and a significant increase in ROS at 30 min. A substantial number of cells were in late apoptosis at 72 h, and a reduction in the mitochondrial membrane potential was also found. Pre-treatment with curcumin nanoformulations increased viability, as well as, reducing ROS at 2 h, 48 h and 72 h. In summary, antioxidants and entrapped nanoformulations of curcumin were able to ameliorate reduced cell viability and increased ROS caused by ethanol treatment. This demonstrates their potential at mitigating oxidative damage and warrants further investigation to evaluate their efficacy for ARLD therapy.

Indexed as

CurcuminLiver Diseases, AlcoholicNanoparticlesOxidative StressAntioxidantsApoptosisCell SurvivalEthanolHep G2 CellsHumansMembrane Potential, MitochondrialMitochondriaReactive Oxygen SpeciesAntioxidantsCurcuminEthanolReactive Oxygen SpeciesAlcoholAntioxidantsCurcuminLiverMitochondriaOxidative stressReactive oxygen species

Identifiers

PMID40044747
PMCPMC11882943

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.